Bloomberg: Aetna to Lower Costs for Most HIV Drugs After Complaint

Bloomberg: Aetna to Lower Costs for Most HIV Drugs After Complaint

By Zachary Tracer

(Bloomberg) — Aetna Inc. has agreed to reduce out-of-pocket payments for most HIV and AIDS medicines after pressure from an advocacy group, revising coverage that had some patients paying $1,000 a month for the drugs.

Before the change, Aetna put almost all HIV drugs in its highest category of cost sharing, asking patients to pay as much as half the expense of high-priced medicines, according to the AIDS Institute. The health insurer will move the drugs into a category that will charge patients $5 to $100 after deductibles are met, the nonprofit institute said Thursday. Cynthia Michener, an Aetna spokeswoman, confirmed the change. Read the full article here. »

Related Content

For almost 50 years, the National Health Law Program has fought to expand access to quality health care to low-income individuals and underserved communities. Today we are pleased to launch a newly designed website for our future work to make health care a reality for all people. Please take time to peruse our new site, and sign up for our email updates to learn about us, watch the work we do, and become engaged.

Continue to site